Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

682 evidences · page 27 / 28

22,12 score_unitsThe mean SCD knowledge of participants in the study was 22.12 ± 2.76.

Nigeriadrépanocytosepublié 2020The Pan African medical journalPubMeddocument de 8 observations

1 609 patientsSouth West registered 1,609 patients with sickle cell disease, representing 20.7% of the total enrolled in Nigeria.

Nigeriadrépanocytosepublié 2022Frontiers in geneticseurope_pmcdocument de 8 observations

1,4 %1.4% of the children with sickle cell anaemia had low free T3.

Nigeriadrépanocytose · hypothyroidismpublié 2023Ethiopian journal of health sciencesPubMeddocument de 7 observations

7,7 yearsThe mean age of the 130 children with sickle cell anaemia in the study was 7.7 years with a standard deviation of 4.1 years.

Nigeriadrépanocytosepublié 2021West African journal of medicinePubMeddocument de 5 observations

97,5 %Among 3622 enrolled sickle cell disease patients in Nigeria, the frequency of Hb SS was 97.5%.

Nigeriadrépanocytose · Hb SSpublié 2020Blood cells, molecules & diseaseseurope_pmcdocument de 16 observations

11,2 odds_ratioChildren admitted for Sickle cell disease had an odds ratio of 11.2 for prolonged hospital stay (>72 hours) at the Children Emergency Room of the University of Calabar Teaching Hospital in Nigeria in 2014.

Nigeriadrépanocytoseobservé 2014publié 2019African health sciencesPubMeddocument de 7 observations

239 womenIn a randomized controlled trial in southwest Nigeria, 239 pregnant women with HbSS or HbSC received 100 mg aspirin daily.

Nigeriadrépanocytosepublié 2026The Lancet. Global healthPubMeddocument de 13 observations

4,5 %Among 308 children with sickle cell disease in Nigeria, cerebral artery blood velocity was high in 14 (4.5%).

Nigeriadrépanocytosepublié 2023Archives of disease in childhoodPubMeddocument de 5 observations

42,4 %The prevalence of myocardial ischemia measuring cardiac troponin T alone in children with sickle cell anemia during vaso-occlusive crisis was 42.4%.

Nigeriadrépanocytose · myocardial ischemiaobservé 2019publié 2024Journal of tropical pediatricsPubMeddocument de 6 observations

8 %Folate deficiency was observed in eight percent of the subjects and none of the controls.

Nigeriadrépanocytoseobservé between September 2018 and March 2019publié 2021African health sciencesPubMeddocument de 3 observations

41,1 %Among the participants who were incorrect about their haemoglobin "genotype", 41.1% (23/56) of women who reported their haemoglobin "genotype" as AA were actually AS.

Nigeriadrépanocytose · trait drépanocytairepublié 2021BMC pregnancy and childbirtheurope_pmcdocument de 4 observationsDOI 10.1186/s12884-021-03974-4

7,8 %The median percentage foetal haemoglobin increased from 7.8% to 14% after 12 months of hydroxyurea therapy.

Nigeriadrépanocytosepublié 2020Journal of tropical pediatricsPubMeddocument de 4 observations

86 %For HbAS phenotype, isoelectric focusing showed a specificity of 86%.

Nigeriadrépanocytosepublié 2022Frontiers in geneticseurope_pmcdocument de 23 observations

71 %At the 30% threshold, 71% of the poorest quartile of sickle cell disease patients experienced catastrophic expenditure.

Nigeriadrépanocytosepublié 2022PloS onePubMeddocument de 5 observations

271,1 µmThe SCD group had lower mean macular thickness (MMT) of 271.1 ± 20.2 µm compared to non-SCD group with MMT of 278.5 ± 13.5 µm.

Nigeriadrépanocytosepublié 2025The Nigerian postgraduate medical journalPubMeddocument de 6 observations

69,6 %CYP2C19 *1/*1 genotype frequency was 69.6% in the SCD group.

Nigeriadrépanocytosepublié 2010Journal of clinical pharmacy and therapeuticseurope_pmcdocument de 10 observations

8,6 %The prevalence of chronic kidney disease from stages 3–5 using estimated glomerular filtration rate was 8.6% among patients with sickle cell disease in Ahmadu Bello University Teaching Hospital, Zaria.

NigeriadrépanocytosePubMeddocument de 7 observations

150 000 births_per_yearSickle cell disease affects about 150,000 births annually in Nigeria.

Nigeriadrépanocytosepublié 2017Hemoglobineurope_pmcdocument de 5 observations

Sickle cell disease is the most common genetic disorder in sub-Saharan Africa.

Nigeriadrépanocytosepublié 2025Annals of African medicinePubMeddocument de 12 observations

37,8 %Among 135 physicians caring for SCD patients in a southwestern state of Nigeria, 51 (37.8%) would recommend prenatal SCD diagnosis.

Nigeriadrépanocytosepublié 2020TheScientificWorldJournalPubMeddocument de 9 observations

50 %Nearly 50% of the participants with sickle cell disease-related priapism had never sought medical attention for this complication.

Nigeriadrépanocytosepublié 2020Blood advancesPubMeddocument de 5 observations

0,5 correlation_coefficientThere was a statistically significant positive correlation between BMI and LV mass among the subjects (n = 50, r = 0.5, P < 0.001).

Nigeriadrépanocytosepublié 2021Nigerian journal of clinical practicePubMeddocument de 3 observations

0 %Among 3622 enrolled sickle cell disease patients in Nigeria, the frequency of Hb Sβ thalassemia was 0%.

Nigeriadrépanocytose · Hb Sβ thalassemiapublié 2020Blood cells, molecules & diseaseseurope_pmcdocument de 16 observations

7,5 %Six SCD participants (7.5%) tested positive for atypical erythrocyte alloantibodies.

Nigeriadrépanocytosepublié 2021ImmunohematologyPubMeddocument de 7 observations

28,9 %Left ventricular hypertrophy was observed in 13 out of 45 (28.9%) pediatric sickle cell anaemia patients in steady state.

Nigeriadrépanocytoseobservé 2023publié 2025BMC pediatricsPubMeddocument de 16 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.